Search Results - "Stegaru, Daniela"

  • Showing 1 - 4 results of 4
Refine Results
  1. 1

    The Charcot Neuroarthropathy as Onset of Type 2 Diabetes - a Diagnostic Challenge by Buse, Alexandru-Madalin, Mihai, Doina-Andrada, Lupu, Leonard, Salmen, Teodor, Stegaru, Daniela, Radulian, Gabriela

    Published in Mædica (01-03-2020)
    “…The Charcot neuro-osteoarthropathy is a devastating complication of diabetes, with negative impact on both prognosis and quality of life. Moreover, the…”
    Get full text
    Journal Article
  2. 2

    Diabetic peripheral neuropathy in the outpatient department – a red-flag for associated risk factors and comorbidities by Salmen, Teodor, Pietrosel, Anca Valeria, Mihai, Bianca Margareta, Bohiltea, Roxana-Elena, Mihai, Doina Andrada, Stegaru, Daniela, Dima, Vlad

    Published in Revista română de pediatrie (30-11-2022)
    “…Objectives. To assess the characteristics of patients with type 2 diabetes mellitus (DM) and diabetic peripheral neuropathy (DPN) as compared to patients with…”
    Get full text
    Journal Article
  3. 3

    Continuous glucose monitoring devices: A brief presentation (Review) by Mihai, Doina Andrada, Stefan, Diana Simona, Stegaru, Daniela, Bernea, Georgiana Elena, Vacaroiu, Ileana Adela, Papacocea, Toma, Lupusoru, Mircea Ovidiu Denis, Nica, Adriana Elena, Stiru, Ovidiu, Dragos, Dorin, Olaru, Octavian Gabriel

    Published in Experimental and therapeutic medicine (01-02-2022)
    “…As diabetes prevalence is continuously increasing, better management is needed to achieve blood glucose control, in order to prevent complications and lessen…”
    Get full text
    Journal Article
  4. 4

    Effectiveness and safety of insulin glargine Gla-300 in insulin-naïve type 2 diabetes subjects in a real-life setting-the GOAL_RO trial by Stegaru, Daniela, Nicodim, Simona, Vladu, Delia, Guțu, Olimpia, Onaca, Adriana, Pîrvu, Florina, Moise, Mihaela, Guja, Cristian

    Published in Annals of translational medicine (01-01-2021)
    “…Basal insulin is the first choice for insulin initiation in type 2 diabetes (T2DM), with the second generation of basal insulin analogues having a lower risk…”
    Get full text
    Journal Article